Article

An official American Thoracic Society Policy statement: managing conflict of interest in professional societies.

Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
American Journal of Respiratory and Critical Care Medicine (Impact Factor: 11.04). 10/2009; 180(6):564-80. DOI: 10.1164/rccm.200901-0126ST
Source: PubMed

ABSTRACT Competing interests occur frequently in health care. This results in the potential for conflict of interest (COI). COI can lead to biased generation or assessment of evidence and misinform healthcare decision makers. Declaration of COI is insufficient to neutralize potentially harmful effects. Medical professional societies are obliged to develop robust mechanisms to "manage" COI, particularly in the development of official guidance documents that affect health care.
This document describes the background, methods, and content of the new "American Thoracic Society (ATS) Policy on Management of COI in Official ATS Documents, Projects, and Conferences."
We used existing reviews on COI policies that were prepared for the World Health Organization and for an ATS guideline methodology workshop as the evidence base for this work. We reviewed existing policies of selected organizations and other relevant literature. Members of the ATS Documents Development and Implementation Committee and the ATS Ethics and COI Committee collaborated to draft a COI policy. We used face-to-face meetings, electronic correspondence, and teleconferences to finalize the draft. The policy then underwent review and ultimate approval by the ATS Board of Directors.
The ATS developed a new policy and procedures for declaration and management of COI. These procedures include: (1) self declaration of COI, (2) review of potential participants' COI, (3) disclosure of COI to project participants, (4) refusal or excusal from certain decisions or recommendations when appropriate, (5) disclosure of COI to users of documents or attendees of conferences, (6) handling disputes in COI resolution. This policy includes a tool that may be useful for supporting decision makers in management of COIs as they assess the value and relevance of conflicts.
The ATS Policy on Management of COI in Official ATS Documents, Projects, and Conferences, in effect since March 2008, promises greater organizational transparency. Application and ongoing evaluation of the policy will give the ATS the opportunity to determine its usefulness in specific settings.

0 Bookmarks
 · 
114 Views
  • Article: Conflicts.
    Otolaryngology Head and Neck Surgery 06/2013; 148(6):895-897. · 1.72 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: More than 70 organizations worldwide have adopted the GRADE methodology for guideline development. The ninth iteration of the American Collage of Chest Physicians guidelines (AT9) adopted structural and policy changes that resulted in a greater adherence to GRADE guidance than previous iterations. The most important of these changes include minimizing the impact of financial and intellectual COI; increasing the rigor of evidence evaluation; acknowledging uncertainty in estimates of typical values and preferences; and awareness of the large variability in values and preferences. One of the consequences of the greater adherence to GRADE methodology is an increase in weak versus strong recommendations in AT9. The result of the GRADE process highlights the desirability of higher quality evidence both regarding the outcomes of alternative management strategies, and of the distribution of values and preferences in patients considering those alternatives. It also encourages shared decision making in encounters between physicians and patients. Although some physicians might find the uncertainty underlying medical practice discouraging or unsettling, relative to denying or obscuring the uncertainty, acknowledging and addressing the uncertainty will lead to more credible, realistic and useful recommendations. This article is protected by copyright. All rights reserved.
    Journal of Thrombosis and Haemostasis 06/2013; · 6.08 Impact Factor
  • Revue des Maladies Respiratoires 12/2010; 27(10):1125-1127. · 0.49 Impact Factor